BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/3/2026 1:23:55 AM | Browse: 2 | Download: 1
 |
Received |
|
2026-01-12 01:36 |
|
Peer-Review Started |
|
2026-01-12 01:36 |
|
First Decision by Editorial Office Director |
|
2026-01-30 09:02 |
|
Return for Revision |
|
2026-01-30 09:02 |
|
Revised |
|
2026-02-02 18:56 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-03-12 02:37 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-03-12 08:00 |
|
Articles in Press |
|
2026-03-12 08:00 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-14 07:04 |
|
Publish the Manuscript Online |
|
2026-08-03 01:23 |
| ISSN |
2219-2808 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Minireviews |
| Article Title |
Current and forthcoming pharmacotherapies for adolescent obesity: Evidence-based review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jenyfer M Fuentes-Mendoza, Marcio J Concepción-Zavaleta, Luisa Graciela Dongo-Dueñas, Jose Mariano J Jara-Pianto, Jhosmar Angel Sierra-Martel, Claudio Aldahir Medina-Angulo, Horus Michael Virú-Flores, Jeny J Mendoza-Godoy, Francisca E Zavaleta-Gutiérrez and José Paz-Ibarra |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Marcio J Concepción-Zavaleta, Grupo de Investigación en Neurociencias, Metabolismo, Efectividad Clínica y Sanitaria, Universidad Científica del Sur, 19 Panamericana Sur Km, Villa El Salvador, Lima 15067, Peru. mconcepcion@cientifica.edu.pe |
| Key Words |
Adolescent obesity; Pediatric obesity; Anti-obesity medications; Weight reduction; Adherence; Quality of life |
| Core Tip |
This minireview demonstrates that current evidence confirms that lifestyle interventions are insufficient for severe cases, proposing pharmacotherapy as a clinical necessity, where glucagon-like peptide 1 receptor agonists, especially semaglutide, are positioned as the current standard of care; while critically evaluating the horizon of dual agonists and other combinations. The article identifies new structural barriers such as high costs, global shortages, and strict insurance requirements. It highlights the urgency of conducting new direct comparisons emphasizing the need to integrate data from ongoing Food and Drug Administration-mandated post-marketing surveillance and prospective registries to monitor outcomes in pubertal maturation, bone health, and neurobiological impact. |
| Publish Date |
2026-08-03 01:23 |
| Citation |
Fuentes-Mendoza JM, Concepción-Zavaleta MJ, Dongo-Dueñas LG, Jara-Pianto JMJ, Sierra-Martel JA, Medina-Angulo CA, Virú-Flores HM, Mendoza-Godoy JJ, Zavaleta-Gutiérrez FE, Paz-Ibarra J. Current and forthcoming pharmacotherapies for adolescent obesity: Evidence-based review. World J Clin Pediatr 2026; 15(3): 118730
|
| URL |
https://www.wjgnet.com/2219-2808/full/v15/i3/118730.htm |
| DOI |
https://doi.org/10.5409/wjcp.118730 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
